ATXI

Avenue Therapeutics Inc (ATXI)

US
$ 1.944.3%

Price Chart

Key Statistics

Market Cap
$ 821.05K
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
32.33K
52W High
$ 3.93
52W Low
$ 0.17
Dividend Yield
0.00%
Beta
-0.10

Technicals

50-Day MA
0.24
200-Day MA
1.1917
52 Week High
3.9313
52 Week Low
0.1653

About ATXI

Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases.

Employees
2
Headquarters
Bay Harbor Islands, FL
CEO
Dr. Alexandra MacLean M.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg